An independent group of practicing doctors, pharmacists and other healthcare professionals on the P&T Committee meets often to look at new and existing drugs. They choose drugs for our formulary based on several factors, including how well they work, value to patients, and safety. All drugs on our formulary are approved by the Food and Drug Administration (FDA).
By using a member’s formulary as an input to prescribing decisions, providers can maximize the clinical benefit of pharmacy care, avoid clinically inferior drugs, minimize patient exposure to unnecessary health risk, and reduce waste.
A list of recent updates to our drug lists can be found here.
If you have questions about the formulary of a specific member, you can access the Real Benefit Check tool in your electronic medical record (EMR) platform to view specific drug information.